Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 801–900 of 1,001
Microglia and Brain Disorders: The Role of Vitamin D and Its Receptor
Mirarchi, A., Albi, E., Beccari, T., & Arcuri, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511892 · Cited by 54
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 51
Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1
Sargsyan, S. A., Blackburn, D. J., Barber, S. C., Monk, P. N., & Shaw, P. J. (2009) · Neuroreport · doi:10.1097/wnr.0b013e328331e8fa · Cited by 51
Lin, F.-C., Tsai, C., Lee, J. K.-W., Wu, M., & Lee, C. T. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3367 · Cited by 44
DJ‐1 forms complexes with mutant SOD1 and ameliorates its toxicity
Yamashita, S., Mori, A., Kimura, E., Mita, S., Maeda, Y., Hirano, T., & Uchino, M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06658.x · Cited by 42
Harnessing Immune Alterations in Neurodegenerative Diseases
Björkqvist, M., Wild, E. J., & Tabrizi, S. J. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.034 · Cited by 42
Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS
Kim, S. H., Stiles, S., Feichtmeier, J., Ramesh, N., Zhan, L., Scalf, M., Smith, L. M., Pandey, U. B., & Tibbetts, R. S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx403 · Cited by 39
Badu-Mensah, A., Guo, X., McAleer, C. W., Rumsey, J. W., & Hickman, J. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-70510-3 · Cited by 39
Multiplexed chemogenetics in astrocytes and motoneurons restore blood–spinal cord barrier in ALS
Alami, N. O., Tang, L., Wiesner, D., Commisso, B., Bayer, D., Weishaupt, J. H., Dupuis, L., Wong, P. C., Baumann, B., Wirth, T., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.201900571 · Cited by 42
Cerebral sterile inflammation in neurodegenerative diseases
Otani, K., & Shichita, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00137-4 · Cited by 39
Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis
Broadhead, M. J., Bonthron, C., Waddington, J., Smith, W. V., Lopez, M. F., Burley, S., Valli, J., Zhu, F., Komiyama, N. H., Smith, C., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02412-9 · Cited by 46
Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases
Birmann, P. T., Casaril, A. M., Abenante, L., Penteado, F., Brüning, C. A., Savegnago, L., & Lenardao, E. J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220615124412 · Cited by 42
Iida, M., Katsuno, M., Nakatsuji, H., Adachi, H., Kondo, N., Miyazaki, Y., Tohnai, G., Ikenaka, K., Watanabe, H., Yamamoto, M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu445 · Cited by 37
Mazzini, L., Vescovi, A., Cantello, R., Gelati, M., & Vercelli, A. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1116516 · Cited by 36
Kim, S., Chung, A., Na, J. E., Lee, S. J., Jeong, S. H., Kim, E., Sun, W., Rhyu, I. J., & Park, H. (2019) · Glia · doi:10.1002/glia.23669 · Cited by 43
Li, C., Chen, Y., Chen, X., Wei, Q., Ou, R., Gu, X., Cao, B., & Shang, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15490 · Cited by 41
Sun, H., Hou, Z., Yang, H., Meng, M., Li, P., Zou, Q., Yang, L., Chen, Y., Chai, H., Zhong, H., et al. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1903-z · Cited by 40
The ‘Omics’ of Amyotrophic Lateral Sclerosis
Caballero-Hernández, D. E., Toscano, M. G., Cejudo‐Guillén, M., García‐Martín, M. L., Lopez, S., Franco, J. M., Quintana, F. J., Roodveldt, C., & Pozo, D. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.11.001 · Cited by 45
Zelic, M., Blazier, A. S., Pontarelli, F., LaMorte, M. J., Huang, J., Tasdemir-Yilmaz, O. E., Ren, Y., Ryan, S. K., Shapiro, C., Morel, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.024 · Cited by 45
Hussain, G., Schmitt, F., Henriques, A., Lequeu, T., René, F., Bindler, F., Dirrig‐Grosch, S., Oudart, H., Palamiuc, L., Metz‐Boutigue, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064525 · Cited by 40
Wiley, N. J., Madhankumar, A. B., Mitchell, R. M., Neely, E. B., Rizk, E., Douds, G. L., Simmons, Z., & Connor, J. R. (2012) · Advances in Nanoparticles · doi:10.4236/anp.2012.13007 · Cited by 38
ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis
Tanaka, H., Shimazawa, M., Takata, M., Kaneko, H., Tsuruma, K., Ikeda, T., Warita, H., Aoki, M., Yamada, M., Takahashi, H., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6877-3 · Cited by 45
Glia–neuron interactions in neurological diseases: Testing non-cell autonomy in a dish
Meyer, K., & Kaspar, B. K. (2016) · Brain Research · doi:10.1016/j.brainres.2015.12.051 · Cited by 40
Synaptic Failure: Focus in an Integrative View of ALS
Casas, C., Manzano, R., Vaz, A. R., Osta, R., & Brites, D. M. T. O. (2015) · Brain Plasticity · doi:10.3233/bpl-140001 · Cited by 42
Seki, S., Yamamoto, T., Quinn, K. N., Spigelman, I., Pantazis, A., Olcese, R., Wiedau‐Pazos, M., Chandler, S. H., & Venugopal, S. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1214-19.2019 · Cited by 42
Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis
Seksenyan, A., Ron‐Harel, N., Azoulay, D., Cahalon, L., Cardon, M., Rogeri, P., Ko, M. K., Weil, M., Bulvik, S., Rechavi, G., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00863.x · Cited by 37
State of the art and the dark side of amyotrophic lateral sclerosis
Musarò, A. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i5.62 · Cited by 36
Genetic validation of a therapeutic target in a mouse model of ALS
de Boer, A. S., Koszka, K., Kiskinis, E., Suzuki, N., Davis‐Dusenbery, B. N., & Eggan, K. C. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009351 · Cited by 38
Review: Microglia in protein aggregation disorders: friend or foe?
Gentleman, S. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12017 · Cited by 38
Jaronen, M., Vehviläinen, P., Malm, T., Keksa-Goldsteine, V., Pollari, E., Valonen, P. K., Koıstınaho, J., & Goldsteins, G. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds472 · Cited by 39
Imaging of glia activation in people with primary lateral sclerosis
Paganoni, S., Alshikho, M. J., Zürcher, N. R., Cernasov, P., Babu, S., Loggia, M. L., Chan, J. G. M., Chonde, D. B., Izquierdo‐Garcia, D., Catana, C., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.10.024 · Cited by 36
Zhao, W., Beers, D. R., Thonhoff, J. R., Thome, A. D., Faridar, A., Wang, J., Wen, S., Ornelas, L., Sareen, D., Goodridge, H. S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101192 · Cited by 43
Jagaraj, C. J., Parakh, S., & Atkin, J. D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.581950 · Cited by 40
Kabashi, E., Agar, J. N., Hong, Y., Taylor, D. M., Minotti, S., Figlewicz, D. A., & Durham, H. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05317.x · Cited by 36
Laferrière, F., & Polymenidou, M. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14054 · Cited by 54
Phosphorylation of C-terminal tyrosine 526 in FUS impairs its nuclear import
Darovic, S., Mihevc, S. P., Župunski, V., Gunčar, G., Štalekar, M., Lee, Y., Shaw, C. E., & Rogelj, B. (2015) · Journal of Cell Science · doi:10.1242/jcs.176602 · Cited by 47
Bowerman, M., Murray, L. M., Scamps, F., Schneider, B. L., Kothary, R., & Raoul, C. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.12.001 · Cited by 50
Микроглия в гомеостазе центральной нервной системы и нейровоспалении
Gogoleva, V. S., Друцкая, М. С., & Атретханы, К.-С. Н. (2019) · Molecular Biology · doi:10.1134/s0026898419050057 · Cited by 48
What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy
Manzano, R., Toivonen, J. M., Moreno‐Martínez, L., de la Torre, M., Moreno‐García, L., López‐Royo, T., Molina, N., Zaragoza, P., Calvo, A. C., & Osta, R. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15276 · Cited by 35
Bowerman, M., Salsac, C., Coque, E., Eiselt, E., Goguyer‐Deschaumes, R., Brodovitch, A., Burkly, L. C., Scamps, F., & Raoul, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv094 · Cited by 37
Bataveljić, D., Stamenković, S., Bačić, G., & Andjus, P. (2011) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.98.2011.1.4 · Cited by 38
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
Richardson, P. J., Smith, D. P., de Giorgio, A., Snetkov, X., Almond-Thynne, J., Cronin, S., Mead, R. J., McDermott, C. J., & Shaw, P. J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00380-y · Cited by 40
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 42
Defective axonal transport in motor neuron disease
El‐Kadi, A. M., Soura, V., & Hafezparast, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21188 · Cited by 41
Peviani, M., Caron, I., Pizzasegola, C., Gensano, F., Tortarolo, M., & Bendotti, C. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791556096 · Cited by 37
Bonifacino, T., Musazzi, L., Milanese, M., Seguini, M., Marte, A., Gallia, E., Cattaneo, L., Onofri, F., Popoli, M., & Bonanno, G. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.011 · Cited by 35
Dou, F., Chu, X., Zhang, B., Liang, L., Lü, G., Ding, J., & Chen, S. (2018) · Molecular Brain · doi:10.1186/s13041-018-0418-z · Cited by 34
Neurochemical biomarkers in amyotrophic lateral sclerosis
Verde, F., Silani, V., & Otto, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000744 · Cited by 40
Genome Editing for CNS Disorders
Duarte, F. T., & Déglon, N. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.579062 · Cited by 36
Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis
Traiffort, É., Morisset‐Lopez, S., Moussaed, M., & Zahaf, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073426 · Cited by 37
Dementia, infections and vaccines: 30 years of controversy
Ecarnot, F., Boccardi, V., Calcagno, A., Franceschi, C., Fülöp, T., Itzhaki, R. F., Michel, J., Panza, F., Rainero, I., Solfrizzi, V., et al. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02409-8 · Cited by 34
Neuronal over‐expression of chromogranin A accelerates disease onset in a mouse model of ALS
Ezzi, S. A., Larivière, R., Urushitani, M., & Julien, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06979.x · Cited by 34
The Imbalance of Vascular Molecules in Alzheimer's Disease
Bell, R. D. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121060 · Cited by 34
Maximino, J. R., de Oliveira, G. P., Alves, C. J., & Chadi, G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00148 · Cited by 40
Boucherie, C., Caumont, A., Maloteaux, J., & Hermans, E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.030 · Cited by 33
Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
Ludolph, A. C., & Jesse, S. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609336399 · Cited by 48
A Review of Experimental Research on Herbal Compounds in Amyotrophic Lateral Sclerosis
Zhang, X., Hong, Y., De-sheng, X., Feng, Y., Zhao, L., Ruan, K., & Yang, X. (2013) · Phytotherapy Research · doi:10.1002/ptr.4960 · Cited by 34
Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis
Trías, E., Ibarburu, S., Barreto‐Núñez, R., & Barbeito, L. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.052 · Cited by 46
The role of immune-mediated alterations and disorders in ALS disease
Rodrigues Lima-Junior, J., Sulzer, D., Lindestam Arlehamn, C. S., & Sette, A. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.01.017 · Cited by 33
Wang, L., Pytel, P., Feltri, M. L., Wrabetz, L. G., & Roos, R. P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.014 · Cited by 41
Lind, A., Wu, D., Freyhult, E., Bodolea, C., Ekegren, T., Larsson, A. O., Gustafsson, M. G., Katila, L., Bergquist, J., Gordh, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149821 · Cited by 35
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
Nizzardo, M., Simoné, C., Rizzo, F., Ulzi, G., Ramirez, A., Rizzuti, M., Bordoni, A., Bucchia, M., Gatti, S., Bresolin, N., et al. (2016) · Scientific Reports · doi:10.1038/srep21301 · Cited by 34
Additive amelioration of ALS by co‐targeting independent pathogenic mechanisms
Frakes, A. E., Braun, L., Ferraiuolo, L., Guttridge, D. C., & Kaspar, B. K. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.375 · Cited by 40
Functional microglia neurotransmitters in amyotrophic lateral sclerosis
Volonté, C., Amadio, S., Fabbrizio, P., & Apolloni, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.014 · Cited by 36
Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System
Silva-Hucha, S., Pastor, Á. M., & Morcuende, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020814 · Cited by 35
MacLean, M., Juranek, J., Cuddapah, S., López-Díez, R., Ruiz, H. H., Hu, J., Frye, L., Li, H., Gugger, P. F., & Schmidt, A. M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02191-2 · Cited by 33
Microglial TREM2 in amyotrophic lateral sclerosis
Xie, M., Zhao, S., Bosco, D. B., Nguyen, A. T., & Wu, L. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22864 · Cited by 36
Muscle Atrophy and Motor Neuron Degeneration in Human NEDL1 Transgenic Mice
Zhang, L., Haraguchi, S., Koda, T., Hashimoto, K., & Nakagawara, A. (2010) · BioMed Research International · doi:10.1155/2011/831092 · Cited by 34
MR Spectroscopy Findings in Early Stages of Motor Neuron Disease
van der Graaff, M. M., Lavini, C., Akkerman, E. M., Majoie, C. B. L. M., Nederveen, A. J., Zwinderman, A. H., Brugman, F., van den Berg, L. H., de Jong, J. M. B. V., & de Visser, M. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2217 · Cited by 39
Transplantation of mesenchymal stem cells in ALS
Mazzini, L., Vercelli, A., Ferrero, I., Boido, M., Cantello, R. M., & Fagioli, F. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59544-7.00016-0 · Cited by 34
Fung, S., Smith, C. S., Prater, K. E., Case, A., Green, K., Osnis, L., Winston, C. N., Kinoshita, Y., Sopher, B. L., Morrison, R. S., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200492 · Cited by 34
Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1G93A ALS Mice
Gaja-Capdevila, N., Hernández, N., Navarro, X., & Herrando-Grabulosa, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.780588 · Cited by 32
“Genetic deletion of mutant SOD1 selectively in microglia increased the lifespan of ALS mice, despite the mutant protein was expressed in MNs and all other cell types (Boillée et al., 2006).”
BackgroundDeng, H., Hujun, J., Fu, R., Hong, Z., Yong, S., Liu, E., Makito, H., Mauro, C. D. C., & Siddique, T. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn131 · Cited by 32
Strategic approaches to developing drug treatments for ALS
Vincent, A. M., Sakowski, S. A., Schuyler, A. D., & Feldman, E. L. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.011 · Cited by 33
The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration
Ferreira, P. A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03029-0 · Cited by 35
Liu, E., Karpf, L., & Bohl, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.767041 · Cited by 34
C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis
Valente, T., Mancera, P., Tusell, J. M., Serratosa, J., & Saura, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.019 · Cited by 35
Olfactory ensheathing glia injections in Beijing: Misleading patients with ALS
Chew, S., Khandji, A. G., Montes, J., Mitsumoto, H., & Gordon, P. H. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701419315 · Cited by 31
Mutant SOD1 detoxification mechanisms in intact single cells
Ganesan, S., Rohde, G., Eckermann, K., Sroka, K., Schaefer, M. K. E., Dohm, C. P., Kermer, P., Haase, G., Wouters, F. S., Bähr, M., et al. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402262 · Cited by 34
Neuroprotective Function of Cellular Prion Protein in a Mouse Model of Amyotrophic Lateral Sclerosis
Steinacker, P., Hawlik, A. E., Lehnert, S., Jahn, O., Meier, S., Görz, E., Braunstein, K. E., Krzovska, M., Schwalenstöcker, B., Jesse, S., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090355 · Cited by 37
Nagano, S., Takahashi, Y., Yamamoto, K., Masutani, H., Fujiwara, N., Urushitani, M., & Araki, T. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv093 · Cited by 31
Díaz‐Amarilla, P., Miquel, E., Trostchansky, A., Trías, E., Ferreira, A. M., Freeman, B. Α., Cassina, P., Barbeito, L., Vargas, M. R., & Rubbo, H. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.013 · Cited by 35
Picher‐Martel, V., Renaud, L., Bareil, C., & Julien, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1411-3 · Cited by 38
Roles of Microglia in Neurodegenerative Diseases
Nakaso, K. (2024) · Yonago acta medica · doi:10.33160/yam.2024.02.001 · Cited by 33
Propagation of the Prion Phenomenon: Beyond the Seeding Principle
Münch, C., & Bertolotti, A. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.061 · Cited by 32
Aurelian, L., & Balan, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05220-4 · Cited by 37
A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
Kim, S. H., Noh, M. Y., Kim, H.-J., Oh, K.-W., Park, J., Lee, S., Moon, Y., Kim, Y.-E., Bae, J. S., Jin, H. K., et al. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.2.33 · Cited by 30
Vucic, S., Ryder, J., Mekhael, L., Henderson, R. D., Mathers, S., Needham, M., Schultz, D. W., & Kiernan, M. C. (2020) · Medicine · doi:10.1097/md.0000000000018904 · Cited by 35
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
Oxidative Stress, Neuroinflammation, and Neurodegeneration
Gao, H., Zhou, H., & Hong, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_5 · Cited by 38
Ryu, H., Jeon, G. S., Cashman, N. R., Kowall, N. W., & Lee, J.-H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.203 · Cited by 31
Phenotypic heterogeneity of astrocytes in motor neuron disease
Trias, E., Barbeito, L., & Yamanaka, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12476 · Cited by 30
Self-citationZhou, C., Zhang, C., Zhao, R., Chi, S., Ge, P. J., & Zhang, C. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-52 · Cited by 30
Targeted stem cell transplantation strategies in ALS
Lepore, A. C., & Maragakis, N. J. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.005 · Cited by 31
Tokuda, E., Watanabe, S., Okawa, E., & Ono, S.-I. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0346-x · Cited by 31
H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis
Nandar, W., Neely, E. B., Simmons, Z., & Connor, J. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.016 · Cited by 31
New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis
Chiot, A., Lobsiger, C. S., & Boillée, S. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000729 · Cited by 36
Self-citationCiervo, Y., Gatto, N., Allen, C. F., Grierson, A. J., Ferraiuolo, L., Mead, R. J., & Shaw, P. J. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.03.017 · Cited by 32
Schweingruber, C., & Hedlund, E. (2022) · Biology · doi:10.3390/biology11081191 · Cited by 34
Li, J., Li, T., Zhang, X., Tang, Y., Yang, J., & Le, W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.003 · Cited by 32
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.